A Novel Method for Detection andex VivoExpansion of HIV Type 1-Specific Cytolytic T Lymphocytes
- 1 November 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 10 (11) , 1427-1431
- https://doi.org/10.1089/aid.1994.10.1427
Abstract
Studies have shown that cytolytic T lymphocyte (CTL) responses may be critical to the clearance of the early viremia in acute HIV-1 infection. It is likely that these cells play an important role in prolonging the asymptomatic phase of the infection. Although HIV-1 -specific CTL activity can be detected in direct assays of freshly isolated peripheral blood lymphocytes (PBL) from some infected individuals, this method fails to detect CTL that are present at low frequency and resting, memory CTL. For these reasons, direct CTL assays on PBL from seropositive individuals may underestimate the level of CTL immunity. As part of ongoing investigations of CTL activity in HIV-1-infected individuals, we developed a novel strategy for the detection and ex vivo expansion of HIV-1-specific CTL. This technique involves selective stimulation of PBL from seropositive individuals with autologous Epstein-Barr virus (EBV)-transformed, B-lymphoblastoid cell lines (B-LCL) infected with vaccinia vectors expressing various HIV-1 genes. Prior to their use for in vitro stimulation, B-LCL are treated with psoralen and UV light to inactivate vaccinia virus. After 1 week of stimulation, CTL activity in stimulated cultures is measured in a standard 51Cr release assay. This ex vivo expansion method can selectively increase the bulk culture CTL activity against env, gag and nef, even in some seropositive individuals with low CD4 counts and little evidence of HIV-1-specific CTL in assays of freshly isolated PBL. These expanded CTL are predominantly of the CD8+ phenotype. This method provides an efficient and sensitive method for the detection and ex vivo expansion of HIV-1 -specific CTL from infected individuals at all stages of disease and may prove useful in following changes in CTL responses with disease progression and therapy. In addition, this method may allow for the ex vivo expansion of HIV-1-specific CTL.Keywords
This publication has 22 references indexed in Scilit:
- Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8 + T cellsAIDS, 1993
- Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.The Journal of Experimental Medicine, 1992
- The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjectsAIDS, 1992
- Induction of CD4 + Human Cytolytic T Cells Specific for HIV-Infected Cells by a Gp160 Subunit VaccineScience, 1990
- Psoralen/UV Inactivation of HIV-1-Infected Cells for Use in Cytologic and Immunologic ProceduresAIDS Research and Human Retroviruses, 1990
- Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.The Journal of Experimental Medicine, 1990
- HIV-specific cytotoxic T lymphocytes in seropositive individualsNature, 1987
- In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.The Journal of Experimental Medicine, 1984
- Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.The Journal of Experimental Medicine, 1981
- Photochemical Inactivation of DNA and RNA Viruses by Psoralen DerivativesJournal of General Virology, 1978